journal article·2025-03Open access

Temporal and Spatial Metabolic Shifts Revealing the Transition from Ulcerative Colitis to Colitis‐Associated Colorectal Cancer

Ruiqi Sun, Yuanyuan Zhang, Xian Zhao, Tian Tang, Yuepeng Cao, Liu Yang, Yuan Tian, Zunjian Zhang, Pei Zhang, Fengguo Xu

Advanced Science· Volume 12· Issue 11

Abstract

Abstract Patients with ulcerative colitis (UC) have a higher risk of developing colorectal cancer (CRC), however, the metabolic shifts during the UC‐to‐CRC transition remain elusive. In this study, an AOM‐DSS‐induced three‐stage colitis‐associated colorectal cancer (CAC) model is constructed and targeted metabolomics analysis and pathway enrichment are performed, uncovering the metabolic changes in this transition. Spatial metabolic trajectories in the “normal‐to‐normal adjacent tissue (NAT)‐to‐tumor” transition, and temporal metabolic trajectories in the “colitis‐to‐dysplasia‐to‐carcinoma” transition are identified through K‐means clustering of 74 spatially and 77 temporally differential metabolites, respectively. The findings reveal two distinct metabolic profile categories during the inflammation‐to‐cancer progression: those with consistent changes, either increasing (e.g., kynurenic acid, xanthurenic acid) or decreasing (e.g., long‐chain fatty acids, LCFAs), and those enriched at specific disease stages (e.g., serotonin). Further analysis of metabolites with consistent temporal trends identifies eicosapentaenoic acid (EPA) as a key metabolite, potentially exerting anti‐inflammatory and anti‐cancer effects by inhibiting insulin‐like growth factor binding protein 5 (IGFBP5). This study reveals novel metabolic mechanisms underlying the transition from UC to CAC and suggests potential targets to delay the progression.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Metabolomics and Mass Spectrometry Studies · Cancer, Hypoxia, and Metabolism · Cancer, Lipids, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education), State Key Laboratory of Natural Medicines China Pharmaceutical University Nanjing 210009 P. R. China

Department of Pharmacy Drum Tower Hospital China Pharmaceutical University Nanjing 210008 P. R. China

School of Pharmacy Air Force Medical University Xi'an 710032 P. R. China

The Affiliated Cancer Hospital of Nanjing Medical University Jiangsu Cancer Hospital Jiangsu Institute of Cancer Research Nanjing 210009 P. R. China

Funding

Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China

References (85)

Show source-provided references
1. 10.1056/NEJMra220086910.1056/NEJMra2200869 ↗
2. 10.1007/s10555-022-10028-410.1007/s10555-022-10028-4 ↗
3. 10.1016/S2468-1253(21)00426-X10.1016/S2468-1253(21)00426-X ↗
4. 10.1016/S1470-2045(21)00588-X10.1016/S1470-2045(21)00588-X ↗
5. 10.1136/jitc-2020-00060910.1136/jitc-2020-000609 ↗
6. 10.1053/j.gastro.2021.10.03510.1053/j.gastro.2021.10.035 ↗
7. 10.1038/s41467-017-01027-z10.1038/s41467-017-01027-z ↗
8. 10.1093/ecco-jcc/jjab10210.1093/ecco-jcc/jjab102 ↗
9. 10.1038/ni.338410.1038/ni.3384 ↗
10. 10.1007/s00384-016-2574-x10.1007/s00384-016-2574-x ↗
11. 10.3390/ijms2118674410.3390/ijms21186744 ↗
12. 10.3389/fcell.2021.71660410.3389/fcell.2021.716604 ↗
13. 10.3390/cancers1414338510.3390/cancers14143385 ↗
14. 10.15252/msb.2014564510.15252/msb.20145645 ↗
15. 10.1016/j.semcancer.2022.01.00410.1016/j.semcancer.2022.01.004 ↗
16. 10.3748/wjg.v28.i30.405310.3748/wjg.v28.i30.4053 ↗
17. 10.1053/j.gastro.2021.04.04210.1053/j.gastro.2021.04.042 ↗
18. 10.1016/j.chroma.2020.46150310.1016/j.chroma.2020.461503 ↗
19. 10.1073/pnas.171036611410.1073/pnas.1710366114 ↗
20. 10.1002/advs.20220053610.1002/advs.202200536 ↗
21. 10.1186/s13045-020-01005-x10.1186/s13045-020-01005-x ↗
22. 10.1016/j.cmet.2015.12.00610.1016/j.cmet.2015.12.006 ↗
23. 10.1038/nrc281710.1038/nrc2817 ↗
24. 10.1016/j.ccell.2015.12.00410.1016/j.ccell.2015.12.004 ↗
25. 10.1038/s41467-021-26685-y10.1038/s41467-021-26685-y ↗
26. 10.1016/j.ccell.2024.07.00510.1016/j.ccell.2024.07.005 ↗
27. 10.1186/s12943-024-02133-510.1186/s12943-024-02133-5 ↗
28. 10.1186/s12943-024-02159-910.1186/s12943-024-02159-9 ↗
29. 10.1049/syb2.1206510.1049/syb2.12065 ↗
30. 10.1093/nsr/nwad16710.1093/nsr/nwad167 ↗
31. 10.1038/s41586-024-07806-110.1038/s41586-024-07806-1 ↗
32. 10.1177/1756284823118498510.1177/17562848231184985 ↗
33. 10.1136/gutjnl-2014-30787310.1136/gutjnl-2014-307873 ↗
34. 10.1053/j.gastro.2011.07.02710.1053/j.gastro.2011.07.027 ↗
35. 10.1186/s13046-015-0221-y10.1186/s13046-015-0221-y ↗
36. 10.1016/j.crohns.2013.03.01310.1016/j.crohns.2013.03.013 ↗
37. 10.1177/2040622323115682610.1177/20406223231156826 ↗
38. 10.4103/0973-1482.14770210.4103/0973-1482.147702 ↗
39. 10.1017/S000711452300035110.1017/S0007114523000351 ↗
40. 10.1158/1055-9965.EPI-20-142610.1158/1055-9965.EPI-20-1426 ↗
41. 10.1016/j.plefa.2013.02.00510.1016/j.plefa.2013.02.005 ↗
42. 10.3390/ijms1904096210.3390/ijms19040962 ↗
43. 10.3390/ijms2411961410.3390/ijms24119614 ↗
44. 10.3390/ijms2404354710.3390/ijms24043547 ↗
45. 10.1093/ecco-jcc/jjaa08610.1093/ecco-jcc/jjaa086 ↗
46. 10.1136/gut.48.4.46810.1136/gut.48.4.468 ↗
47. 10.1038/mt.2014.22210.1038/mt.2014.222 ↗
48. 10.1136/gutjnl-2022-32732310.1136/gutjnl-2022-327323 ↗
49. 10.1016/j.foodchem.2021.13138910.1016/j.foodchem.2021.131389 ↗
50. 10.1039/D1FO03815J10.1039/D1FO03815J ↗
51. 10.3390/nu1419420410.3390/nu14194204 ↗
52. 10.1038/s41598-017-07992-110.1038/s41598-017-07992-1 ↗
53. 10.3390/md2202007610.3390/md22020076 ↗
54. 10.1002/ijc.2885310.1002/ijc.28853 ↗
55. 10.1093/jn/130.5.115310.1093/jn/130.5.1153 ↗
56. 10.1093/carcin/bgx13610.1093/carcin/bgx136 ↗
57. 10.1158/1078-0432.CCR-10-199010.1158/1078-0432.CCR-10-1990 ↗
58. 10.1016/j.cgh.2018.01.03610.1016/j.cgh.2018.01.036 ↗
59. 10.1002/ijc.3445910.1002/ijc.34459 ↗
60. 10.1007/s00394-020-02413-y10.1007/s00394-020-02413-y ↗
61. 10.1136/gut.2009.20064210.1136/gut.2009.200642 ↗
62. 10.1161/CIR.000000000000070910.1161/CIR.0000000000000709 ↗
63. 10.1016/j.pharmthera.2022.10817210.1016/j.pharmthera.2022.108172 ↗
64. 10.1016/j.celrep.2021.11022210.1016/j.celrep.2021.110222 ↗
65. 10.1016/S0899-9007(01)00670-010.1016/S0899-9007(01)00670-0 ↗
66. 10.1016/j.cmet.2022.11.01310.1016/j.cmet.2022.11.013 ↗
67. 10.1016/j.intimp.2023.11104210.1016/j.intimp.2023.111042 ↗
68. 10.1016/j.ccell.2023.02.01610.1016/j.ccell.2023.02.016 ↗
69. 10.1016/j.biopha.2016.12.02410.1016/j.biopha.2016.12.024 ↗
70. 10.1038/s42255-021-00506-410.1038/s42255-021-00506-4 ↗
71. 10.1073/pnas.221490011910.1073/pnas.2214900119 ↗
72. 10.1016/j.bbrc.2018.09.02310.1016/j.bbrc.2018.09.023 ↗
73. 10.1038/s41586-023-05891-210.1038/s41586-023-05891-2 ↗
74. 10.1152/ajpgi.00499.200610.1152/ajpgi.00499.2006 ↗
75. 10.3109/10715762.2012.75698010.3109/10715762.2012.756980 ↗
76. 10.1172/JCI12692310.1172/JCI126923 ↗
77. 10.1126/sciimmunol.abi976810.1126/sciimmunol.abi9768 ↗
78. 10.3390/biom1004049910.3390/biom10040499 ↗
79. 10.1007/978-1-4939-3603-8_2610.1007/978-1-4939-3603-8_26 ↗
80. 10.1038/nprot.2007.4110.1038/nprot.2007.41 ↗
81. Cooper H. S. · Lab Invest. · 1993 · 69 · 238
82. 10.1021/acs.analchem.3c0134310.1021/acs.analchem.3c01343 ↗
83. 10.1016/j.aca.2019.02.00110.1016/j.aca.2019.02.001 ↗
84. 10.1371/journal.pone.000798410.1371/journal.pone.0007984 ↗
85. 10.1155/2008/58672110.1155/2008/586721 ↗